FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Merck Sharp & Dohme Noxafil Powdermix Recall

Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets…

Merck Sharp & Dohme LLC · Wilson, NC

Risk level
Class II
Reported by FDA
Dec 31, 2025
Recall ID
D-0242-2026
Check your lot numberHow we source this data

Summary

Merck Sharp & Dohme recalled Noxafil Powdermix starting Dec 12, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0242-2026 on Dec 31, 2025. Reason: Presence of particulate matter: potential presence of metal particulates in the product. Status: Ongoing.

Why it was recalled

Presence of particulate matter: potential presence of metal particulates in the product.

Product description

Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02.

Lot numbers, UPCs & expiration codes

Lot#: Z012339, Z010344, Z009908, Z009909, Exp Date 12-31-2026

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0242-2026
Classification
Class II
Status
Ongoing
Recall initiated
Dec 12, 2025
FDA report date
Dec 31, 2025
Quantity
845 kits
Recall type
Voluntary: Firm initiated
Recalling firm
Merck Sharp & Dohme LLC

Original FDA data

Every field from FDA enforcement report D-0242-2026, exactly as published.

Show all FDA fields
City
Wilson
State
NC
Status
Ongoing
Country
United States
Event ID
98113
Address
4633 Merck Rd W
Code information
Lot#: Z012339, Z010344, Z009908, Z009909, Exp Date 12-31-2026
Postal code
27893-9613
Report date
Dec 31, 2025
Product type
Drugs
Recall number
D-0242-2026
Classification
Class II
Recalling firm
Merck Sharp & Dohme LLC
Product quantity
845 kits
Reason for recall
Presence of particulate matter: potential presence of metal particulates in the product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02.
Distribution pattern
Nationwide in the USA
Recall initiation date
Dec 12, 2025
Initial firm notification
Letter
Center classification date
Dec 23, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0242-2026, published Dec 31, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls